Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004135 (
ATM
)
13,001
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Immunoglobulin class switch recombination (Ig
CSR
) involves DNA double strand breaks (DSBs) at recombining switch regions and repair of these breaks by nonhomologous end-joining. Because the protein kinase ataxia telengiectasia (AT) mutated (
ATM
) plays a critical role in DSB repair and AT patients show abnormalities of Ig isotype expression, we assessed the role of
ATM
in
CSR
by examining
ATM
-deficient mice. In response to T cell-dependent antigen (Ag), Atm-/- mice secreted substantially less Ag-specific IgA, IgG1, IgG2b, and IgG3, and less total IgE than Atm+/+ controls. To determine whether Atm-/- B cells have an intrinsic defect in their ability to undergo
CSR
, we analyzed in vitro responses of purified B cells. Atm-/- cells secreted substantially less IgA, IgG1, IgG2a, IgG3, and IgE than wild-type (WT) controls in response to stimulation with lipopolysaccharide, CD40 ligand, or anti-IgD plus appropriate cytokines. Molecular analysis of in vitro responses indicated that WT and Atm-/- B cells produced equivalent amounts of germline IgG1 and IgE transcripts, whereas Atm-/- B cells produced markedly reduced productive IgG1 and IgE transcripts. The reduction in isotype switching by Atm-/- B cells occurs at the level of genomic DNA recombination as measured by digestion-circularization PCR. Analysis of sequences at
CSR
sites indicated that there is greater microhomology at the mu-gamma1 switch junctions in
ATM
B cells than in wild-type B cells, suggesting that
ATM
function affects the need or preference for sequence homology in the
CSR
process. These findings suggest a role of
ATM
in DNA DSB recognition and/or repair during
CSR
.
...
PMID:Immunoglobulin class switch recombination is impaired in Atm-deficient mice. 1550 20
The interplay between
ATM
and DNA-PKcs kinases during double strand breaks (DSBs) resolution is still a matter of debate.
ATM
and DNA-PKcs participate differently in the DNA damage response pathway (DDR), but important common aspects are indeed found: both of them are activated when faced with DSBs, they share common targets in the DDR and the absence of either kinase results in faulty DSB repair. Absence of
ATM
translates into timely repair that, nevertheless, is incomplete. On the other hand, DNA-PKcs absence translates into slower repair, which in turn gives rise to the accumulation of simple and complex reorganizations. These outcomes confirm that the function of both protein kinases is essential to guarantee genome integrity. Interestingly, V(D)J and
CSR
recombination events provide a powerful tool to study the interplay between both kinases in DSB repair. Although the physiological DSBs generated during V(D)J and
CSR
recombination are resolved by the non-homologous end-joining (NHEJ) repair pathway,
ATM
absence during these events translates into chromosome translocations. These results suggest that NHEJ accuracy is threatened in the absence of
ATM
, which may play a role in avoiding illegitimate repair by favouring the joining of the correct DNA ends. Indeed, simultaneous DNA-PKcs and
ATM
deficiency during V(D)J and
CSR
recombination translates into a synergistic increase in potentially dangerous chromosomal translocations and deletions. Although the exact nature of their interaction remains elusive, the evidence indicates that
ATM
and DNA-PKcs play complementary roles that allow complete and legitimate DSB repair to be reached. Faithful repair can only be achieved by the presence and correct functioning of both kinases: while DNA-PKcs ensures fast rejoining,
ATM
guarantees complete repair.
...
PMID:ATM and DNA-PKcs make a complementary couple in DNA double strand break repair. 2223 May 47